Amanote Research

Amanote Research

    RegisterSign In

Treatment of Minimal Residual Disease in Breast Cancer: A Longitudinal Case Study

Cureus
doi 10.7759/cureus.1521
Full Text
Open PDF
Abstract

Available in full text

Date

July 27, 2017

Authors
Nigel P Murray
Publisher

Cureus, Inc.


Related search

Minimal Residual Disease

Leukemia Supplements
2012English

Minimal Residual Disease

Bone Marrow Transplantation
TransplantationHematology
2001English

Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2016English

Workshop on Minimal Residual Disease

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2001English

Limitations of the Use of Single Base Changes in the P53 Gene to Detect Minimal Residual Disease of Breast Cancer

Molecular Pathology
2002English

Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?

Frontiers in Oncology
Cancer ResearchOncology
2019English

Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2007English

Post-Neoadjuvant Treatment and the Management of Residual Disease in Breast Cancer: State of the Art and Perspectives

Therapeutic Advances in Medical Oncology
Oncology
2019English

Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future Directions

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy